Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:WMB
NYSE:WMBOil and Gas

Assessing Williams Companies (WMB) Valuation After Recent Share Price Momentum Cooldown

Williams Companies (WMB) is back on investors’ radar after recent share price moves, with the stock showing mixed returns over the past week and month while remaining meaningfully higher over the past 3 months and year. See our latest analysis for Williams Companies. Short term momentum has cooled, with a 1 month share price return of a 3.01% decline following prior gains that left the 3 month share price return at 20.46% and the 1 year total shareholder return at 25.24%. This may hint at...
SGX:C07
SGX:C07Industrials

A Look At Jardine Cycle & Carriage (SGX:C07) Valuation As New CEO And Finance Director Are Announced

Leadership reshuffle and what it might mean for Jardine Cycle & Carriage Jardine Cycle & Carriage (SGX:C07) has announced a leadership reshuffle, with current Group Finance Director Freddy Lee set to become Chief Executive Officer and long serving finance executive Ng Yang Yen stepping up as Finance Director from 1 May 2026. See our latest analysis for Jardine Cycle & Carriage. These leadership changes come as Jardine Cycle & Carriage trades at SGD35.34, with recent momentum reflected in a...
OM:INTEA B
OM:INTEA BReal Estate

European Undervalued Small Caps With Insider Buying For March 2026

As European markets navigate the uncertainty surrounding the Middle East conflict and its impact on energy prices, small-cap stocks have drawn attention for their potential resilience and growth opportunities. In this environment, identifying undervalued small-cap companies with insider buying can be a strategic approach to finding promising investments amid broader market volatility.
XTRA:NEM
XTRA:NEMSoftware

A Look At Nemetschek (XTRA:NEM) Valuation After Strong Full Year 2025 Results

Nemetschek (XTRA:NEM) is back in focus after releasing full year 2025 results, reporting sales of €1,191.23 million and net income of €217.24 million compared with the prior year. See our latest analysis for Nemetschek. The latest full year results have put Nemetschek back on investors’ radar. However, the share price tells a more cautious story, with a 90 day share price return showing a decline of 32.44% and a 1 year total shareholder return showing a loss of 41.02%. This suggests momentum...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Assessing Incyte (INCY) Valuation After Recent Share Price Weakness And Mixed Fair Value Signals

Without a specific news catalyst, Incyte (INCY) has attracted attention after a period where the share price shows a one-month return of about negative 11% and a past three-month return around negative 9%. See our latest analysis for Incyte. At a share price of $90.33, the recent 1 month share price return of around an 11% decline continues the softer trend seen over 3 months and year to date, even though the 1 year total shareholder return of about 49% and 3 year total shareholder return of...
NYSE:GRDN
NYSE:GRDNHealthcare

Does Guardian’s US$186 Million Equity Raise and New Governance Committee Reshape the Bull Case for GRDN?

Guardian Pharmacy Services, Inc. recently completed a follow-on equity offering of 6,000,000 Class A common shares at US$31.00 each, raising about US$186,000,000, and its board also formed a Nominating and Governance Committee chaired by independent director Mary Sue Patchett. This combination of fresh equity capital and enhanced board governance could shape how Guardian funds future growth while reinforcing oversight of board appointments and corporate policies. We will now examine how...
NYSE:ZGN
NYSE:ZGNLuxury

A Look At Zegna (ZGN) Valuation After Full Year Earnings And Proposed Dividend

Ermenegildo Zegna (ZGN) is in focus after reporting full year 2025 results, with sales of €1,916.95 million, net income of €98.58 million, and a proposed €0.12 per share dividend, pending shareholder approval. See our latest analysis for Ermenegildo Zegna. The earnings release and proposed dividend come after a mixed period for the stock, with a 12.6% decline in the 30 day share price return and a 35.2% gain in the 1 year total shareholder return, suggesting longer term holders have fared...
OB:VEND
OB:VENDInteractive Media and Services

High Growth Tech Stocks In Europe For March 2026

As European markets navigate the complexities of geopolitical tensions and fluctuating energy prices, the pan-European STOXX Europe 600 Index has managed a modest gain, reflecting cautious optimism amid uncertainty. In this environment, selecting high-growth tech stocks requires a focus on companies with robust innovation capabilities and resilience to external shocks, as these attributes can help them thrive despite broader economic challenges.
NYSE:GEV
NYSE:GEVElectrical

Is It Too Late To Consider GE Vernova (GEV) After A 168.5% One-Year Surge?

If you are wondering whether GE Vernova's current share price really matches its potential, you are not alone. Many investors are trying to work out what a fair value looks like for this stock. The share price recently closed at US$817.35, with returns of 20.3% year to date and 168.5% over the last year, alongside 7.4% and 6.4% declines across the past 7 and 30 days respectively. Recent moves have come as investors continue to react to GE Vernova's position within the broader capital goods...
OM:VIMIAN
OM:VIMIANMedical Equipment

March 2026 European Stocks Trading At Estimated Discounts

As European markets navigate the uncertainty surrounding the Middle East conflict and its impact on economic growth, investors are keenly observing how these developments influence stock valuations. In this context, identifying undervalued stocks becomes crucial, as they may present opportunities for those looking to capitalize on potential market inefficiencies amid ongoing geopolitical and economic challenges.
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio-Techne’s New COMET Spatial Tools Might Change The Case For Investing In Bio-Techne (TECH)

In March 2026, Bio-Techne Corporation expanded its COMET spatial biology portfolio by introducing new SPYRE Focus Panels, SPYRE Amplification Kits using seqLA technology, and upgraded HORIZON Image Analysis Software to enhance automated, high-plex tissue analysis from assay design through interpretation. An interesting aspect is how the modular SPYRE antibody panels and amplification tools are designed to plug into existing lab workflows, potentially shortening optimization timelines while...
HLSE:KESKOB
HLSE:KESKOBConsumer Retailing

A Look At Kesko Oyj’s Valuation As AGM Confirms 2025 Dividend And New Board Appointment

Kesko Oyj (HLSE:KESKOB) is back in focus after its 2026 Annual General Meeting confirmed a €0.90 per share dividend for 2025 and added Mervi Airaksinen to both the Board and Audit Committee. See our latest analysis for Kesko Oyj. At a share price of €19.15, the stock has had a 1 day share price return of 1.38% and a 30 day share price return of an 8.20% decline. The 1 year total shareholder return of 6.36% and 3 year total shareholder return of 13.54% point to steadier progress, suggesting...
NYSE:BBU
NYSE:BBUIndustrials

Brookfield Business Partners (BBU) Valuation After S&P TSX Income Trust Index Removal

Index removal and shelf registration use draw fresh attention Brookfield Business Partners (BBU) recently dropped out of the S&P/TSX Income Trust Index, a change that can affect fund flows. The partnership has also fully used its 2023 shelf registration for limited partnership units. See our latest analysis for Brookfield Business Partners. Recent trading reflects that tension clearly, with a 1-month share price return of a 7.69% decline and a 90-day share price return of an 11.28% decline,...
NYSE:PFE
NYSE:PFEPharmaceuticals

Is It Time To Reconsider Pfizer (PFE) After Diverging Valuation Narratives?

If you are wondering whether Pfizer's current share price reflects its underlying value, you are not alone. This article is designed to help you frame that question clearly. Find out why Pfizer's 17.5% return over the last year is lagging behind its peers. Approach 1: Pfizer Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s dollars to estimate what the business might be worth right now. For...
NasdaqGS:CECO
NasdaqGS:CECOMachinery

Is It Too Late To Consider CECO Environmental (CECO) After Its 147% One Year Surge?

If you are wondering whether CECO Environmental at around US$57 is still offering value or if most of the easy gains are already behind it, this breakdown is for you. The stock recently pulled back with an 8.1% decline over 7 days and a 5.7% decline over 30 days, while the 1 year return sits at 146.9% and the 3 year return is very large. Recent headlines have focused on CECO Environmental as an environmental solutions provider, highlighting how it is positioned around air pollution control,...
BME:MRL
BME:MRLREITs

A Look At MERLIN Properties SOCIMI (BME:MRL) Valuation After Its €767.6m Follow On Equity Offering

MERLIN Properties SOCIMI follow on offering: what the new capital means for shareholders MERLIN Properties SOCIMI (BME:MRL) has completed a follow on equity offering of €767.6m, issuing 56,275,101 new common shares at €13.64. For investors, this raises questions around dilution, capital use and future capital allocation priorities. See our latest analysis for MERLIN Properties SOCIMI. At a share price of €13.79, MERLIN’s 30 day share price return of an 8.13% decline contrasts with its 11.03%...
ENXTPA:VU
ENXTPA:VUElectronic

European Growth Companies With High Insider Ownership

In the current European market, investor sentiment is being shaped by geopolitical uncertainties and fluctuating energy prices, with indices like the STOXX Europe 600 showing modest gains amid these challenges. As economic conditions remain unpredictable, growth companies with high insider ownership can offer a unique appeal due to their potential for alignment between management and shareholder interests, which may be particularly valuable in navigating complex market environments.
DB:20B
DB:20BBiotechs

European Penny Stocks To Watch: 3 Picks Below €30M Market Cap

As European markets navigate the uncertainties surrounding geopolitical tensions in the Middle East and fluctuating energy prices, investors are keenly observing opportunities within various sectors. Penny stocks, though often seen as a throwback to earlier trading days, remain a compelling area of interest due to their potential for significant growth. These smaller or newer companies can offer unique investment opportunities when they possess solid financial foundations and strong...
NasdaqGS:LECO
NasdaqGS:LECOMachinery

A Look At Lincoln Electric (LECO) Valuation After Recent Share Price Pullback

Lincoln Electric Holdings (LECO) has drawn attention after recent share price softness, with the stock down about 15% over the past month even as its 1 year total return is near 29%. See our latest analysis for Lincoln Electric Holdings. The recent 14.9% 1 month share price decline, alongside a softer 7 day share price return of 4.1% and a modest 1.9% 90 day share price gain, contrasts with Lincoln Electric Holdings' stronger 1 year total shareholder return of 28.8%. This suggests momentum...
TSX:TXG
TSX:TXGMetals and Mining

A Look At Torex Gold Resources (TSX:TXG) Valuation After Updated Reserves And Los Reyes Addition

Torex Gold Resources (TSX:TXG) has updated its year end 2025 mineral reserves and resources for the Morelos Complex and Los Reyes, highlighting fresh drilling results, changes to its geological models, and upcoming economic studies. See our latest analysis for Torex Gold Resources. The updated reserve and resource figures arrive after a sharp 28.77% 1 month share price decline and an 11.42% 3 month share price decline, yet the 1 year total shareholder return of 49.20% and 5 year total...
NYSE:EPC
NYSE:EPCPersonal Products

A Look At Edgewell Personal Care (EPC) Valuation After ESOP-Linked Shelf Registration Filing

Edgewell Personal Care (EPC) has filed a US$45.701 million shelf registration for up to 2,300,000 common shares tied to its Employee Stock Ownership Plan, raising fresh questions about potential dilution and capital allocation priorities. See our latest analysis for Edgewell Personal Care. At a share price of US$21.43, Edgewell Personal Care has seen a 9.84% 7 day share price return and a 25.03% 90 day share price return. However, the 1 year total shareholder return of 29.41% and 3 year total...
ENXTPA:CRBP2
ENXTPA:CRBP2Banks

Uncovering March 2026 Undiscovered Gems in Europe

As European markets navigate the uncertainties brought on by the Middle East conflict and its impact on energy prices, the pan-European STOXX Europe 600 Index has managed a modest advance of 0.35%, reflecting a cautious optimism amid global volatility. With the European Central Bank signaling potential policy adjustments in response to inflationary pressures, investors are keenly observing small-cap opportunities that can weather these macroeconomic challenges while offering growth...